Clinical Trials · NCT01430195
Afamelanotide and Narrow-Band Ultraviolet B (NB-UVB) Light in the Treatment of Nonsegmental Vitiligo (NSV)
- Phase
- Phase 1
- Recruitment status
- Completed
- Sponsor
- Clinuvel Pharmaceuticals Limited
- Enrollment
- 56
- Start date
- Jun 2011
- Locations
- 2 sites, United States
- Primary endpoint
- Pigmentation of full body, face, trunk and extremities using the VASI and VETF scores